Home › Hypertrophic Cardiomyopathy › North Carolina
Hypertrophic Cardiomyopathy clinical trials in North Carolina
3 studies for Hypertrophic Cardiomyopathy are looking for participants at sites in North Carolina.
Cities in North Carolina
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
- Focus Clinical Research, Charlotte
- Duke University Health System, Durham
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT05489705A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
- Imbria Investigational Site, Charlotte
RecruitingPhase 2
Ages 18 and older · All sexes · Updated May 18, 2026 · NCT07023614Mavacamten Pregnancy Surveillance Program
- The Mavacamten Pregnancy Surveillance Program, PPD Inc, Wilmington
RecruitingObservational study
Ages 15 and older · Women · Updated Nov 6, 2025 · NCT05939700From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.